RegentAtlantic Capital’s Align Technology ALGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
$1.04M Buy
5,013
+77
+2% +$19.8K 0.03% 303
2022
Q2
$1.17M Buy
4,936
+2,809
+132% +$863K 0.04% 287
2022
Q1
$927K Buy
2,127
+209
+11% +$102K 0.03% 329
2021
Q4
$1.26M Buy
1,918
+46
+2% +$29.6K 0.04% 288
2021
Q3
$1.25M Buy
1,872
+253
+16% +$172K 0.04% 271
2021
Q2
$989K Buy
1,619
+462
+40% +$273K 0.03% 296
2021
Q1
$627K Buy
+1,157
New +$640K 0.02% 348
2015
Q1
Sell
-69
Closed -$3.86K 381
2014
Q4
$3.86K Buy
+69
New +$3.65K ﹤0.01% 1050

Other funds holding ALGN

RegentAtlantic Capital's ALGN Position: Q3 2022 in Review

RegentAtlantic Capital increased its Align Technology (ALGN) stake by 1.6% in Q3 2022, buying an estimated $19.8K and bringing the position to 5,013 shares worth $1.04M. The position accounts for 0.03% of the portfolio, ranked #303.

RegentAtlantic Capital first reported a position in ALGN in Q4 2014 and has held it in 8 quarters since. The position peaked at $1.26M in Q4 2021. 730 funds tracked by Wall St. Rank hold ALGN as of Q3 2022.

  • RegentAtlantic Capital held 5,013 shares of Align Technology worth $1.04M as of Q3 2022.
  • RegentAtlantic Capital bought 77 Align Technology shares in Q3 2022, an estimated $19.8K.
  • Align Technology made up 0.03% of RegentAtlantic Capital's portfolio in Q3 2022, its #303 holding.
  • RegentAtlantic Capital first reported a position in Align Technology in Q4 2014 and has held it in 8 quarters since.
  • RegentAtlantic Capital's Align Technology position peaked at $1.26M in Q4 2021.
  • 730 funds tracked by Wall St. Rank held Align Technology as of Q3 2022.

Based on RegentAtlantic Capital's 13F filing for Q3 2022, filed 14 Nov 2022.